Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 351

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 351
---
)(2) of the Securities Act.​​

#### II-2
Item 16. Exhibits and Financial Statement Schedules. (a) Exhibits

| ​       
 Exhibit 
 No.     
 2.1     
 2.2     | ​ 
 ​ 
 ​ | ​                                                                                                                                                                                                                                                                                                                                                                    
 Description                                                                                                                                                                                                                                                                                                                                                          
 Business Combination Agreement, dated November 30, 2022, as amended, by and among Iris Acquisition Corp, Iris Parent Holding Corp., Liminatus Pharma, LLC, Liminatus Pharma Merger Sub, Inc. and SPAC Merger Sub, Inc. (incorporated by reference to Annex A to the proxy statement/prospectus filed with the SEC on February 7, 2025).                              
 Certificate of Merger of Liminatus Pharma, LLC and Liminatus Pharma Merger Sub, Inc. filed on April 30, 2025 (incorporated by reference to Exhibit 2.2 to the registrant’s Current Report on Form 8-K filed with the SEC on May 6, 2025).                                                                                                                            |
|:--------|:--|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.3     | ​ | Certificate of Merger of Iris Acquisition Corp and SPAC Merger Sub, Inc. filed on April 30, 2025 (incorporated by reference to Exhibit 2.3 to the registrant’s Current Report on Form 8-K filed with the SEC on May 6, 2025).                                                                                                                                        |
| 3.1     | ​ | Amended and Restated Certificate of Incorporation of Iris Parent Holding Corp. (renamed Liminatus Pharma, Inc.) filed on April 30, 2025 (incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the SEC on May 6, 2025).                                                                                                 |
| 3.2     | ​ | Amended and Restated Bylaws of Iris Parent Holding Corp. (renamed Liminatus Pharma, Inc.) (incorporated by reference to Annex I to the proxy statement/prospectus filed with the SEC on February 7, 2025).                                                                                                                                                           |
| 4.1     | ​ | Specimen Common Stock Certificate (incorporated by reference to Exhibit 4.1 of the Registration Statement on Form S-4 (File No. 333-275409), filed by the Registrant with the